Save on Brand-Name Drugs in District of Columbia
Compare Brand-Name Drugs prices across District of Columbia pharmacies. Save up to 66% — no insurance required.
Top Brand-Name Drugs for District of Columbia Residents
Humira (adalimumab)
Eliquis (apixaban)
Ozempic (semaglutide)
Keytruda (pembrolizumab)
Biktarvy (bictegravir/emtricitabine/TAF)
District of Columbia Prescription Assistance Programs
DC Medicaid Rx (DC Health Care Alliance)
Prescription drug coverage for DC Medicaid beneficiaries and uninsured DC residents with incomes up to 200% FPL through the DC Health Care Alliance program.
Eligibility: Low-income DC residents including adults up to 215% FPL for Medicaid, and uninsured adults through the Alliance program.
DCPAP (DC Pharmaceutical Assistance Program)
Assists eligible low-income DC seniors with Medicare Part D co-payments and coverage gaps.
Eligibility: DC residents aged 65+ enrolled in Medicare Part D with income at or below 300% FPL. Contact the DC Office on Aging at 202-724-5622.
Frequently Asked Questions
Why do brand-name drugs cost so much?
Pharmaceutical companies recover research, development, clinical trial, and regulatory costs through patent-protected pricing. Marketing and distribution costs are also factored in. Competition arrives only when patents expire.
Can manufacturer co-pay cards be used with ScriptUnlock pharmacies?
Yes. Many ScriptUnlock partner pharmacies accept manufacturer co-pay assistance cards. Check the specific program terms; some exclude patients with government insurance.
Is there a biosimilar for Humira?
Yes. Multiple FDA-approved adalimumab biosimilars launched in 2023, with prices 30–85% below brand Humira. ScriptUnlock bids include available adalimumab biosimilar options.
What is a "patient assistance program" for brand drugs?
Manufacturer-run programs that provide free or heavily discounted brand medications to eligible patients (usually income-based). ScriptUnlock pharmacy partners can guide you through applying.
How do I know if a brand drug has a generic yet?
The FDA's Orange Book lists patent expiries and approved generics. ScriptUnlock automatically surfaces any available generic alternative alongside brand bids so you can make an informed choice.